Treatment of inflammatory bowel disease patients with anti-TNF-α factors and immunosuppressives does not influence the prevalence of Helicobacter pylori infection

John K. Triantafillidis, Aristofanis Gikas, Emmanuel Merikas
  • Indian Journal of Gastroenterology, September 2013, Springer Science + Business Media
  • DOI: 10.1007/s12664-013-0389-z

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Aristofanis Gikas and Dr Aristofanis Gikas